Potential New Cancer Treatment Activates Cancer-Engulfing Cells: Figure 4 (IMAGE)

Kobe University

Potential New Cancer Treatment Activates Cancer-Engulfing Cells: Figure 4

Caption

Figure 4: Anti-SIRPα antibodies strengthen the anti-tumor effects of immune checkpoint molecule inhibitors (anti-PD-1 antibodies). Anti-SIRPα antibodies strengthen the tumor-killing effect of anti-PD-1 antibodies on subcutaneous mouse colon carcinoma (CT26).

Credit

Kobe University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.